Literature DB >> 10469804

Patient recruitment--European perspective.

K Hoppu1.   

Abstract

A considerable number of patients have to be recruited in a clinical trial to obtain solid results. In pediatric studies, patient recruitment is frequently problematic. In the simple common childhood illnesses, the number of recruitable patients is certainly large, but they may be hard to reach, and the imbalance between potential benefit and inconvenience of participation may reduce motivation to enroll. In severe diseases, the balance may be right, but the available number of patients may be small. Good communication with the child and family, as well as the motivation of colleagues to admit, is another key element in success. Proper study design, including realistically identified sources of patients, reasonable inclusion, and exclusion criteria, also are required.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469804

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Frontline ethical issues in pediatric clinical research: ethical and regulatory aspects of seven current bottlenecks in pediatric clinical research.

Authors:  Wim Pinxten; Herman Nys; Kris Dierickx
Journal:  Eur J Pediatr       Date:  2010-07-29       Impact factor: 3.183

2.  Regulating trust in pediatric clinical trials.

Authors:  Wim Pinxten; Herman Nys; Kris Dierickx
Journal:  Med Health Care Philos       Date:  2008-07-18

3.  Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials.

Authors:  Wim Pinxten; Kris Dierickx; Herman Nys
Journal:  Eur J Pediatr       Date:  2009-01-14       Impact factor: 3.183

4.  Grassroots campaign trail methods to recruit for clinical trials: recruitment lessons learned from trail to trial.

Authors:  Megan Murphy; Daniel Merenstein
Journal:  Clin Med Insights Pediatr       Date:  2011-02-23

5.  Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.

Authors:  April V P Clyburne-Sherin; Pravheen Thurairajah; Mufiza Z Kapadia; Margaret Sampson; Winnie W Y Chan; Martin Offringa
Journal:  Trials       Date:  2015-09-18       Impact factor: 2.279

6.  Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.

Authors:  Rachel E Sobel; Daniel J Lovell; Hermine I Brunner; Jennifer E Weiss; Paula W Morris; Beth S Gottlieb; Elizabeth C Chalom; Lawrence K Jung; Karen B Onel; Lisa Petiniot; Donald P Goldsmith; Kabita Nanda; Michael Shishov; Staci Abramsky; James P Young; Edward H Giannini
Journal:  Pediatr Rheumatol Online J       Date:  2014-07-16       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.